If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans ...

The Federal Trade Commission said in its second interim staff report on prescription-drug middlemen that the "significant markups" in prices above what the drugs cost generated an extra $7.3 billion ...

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

The Federal Trade Commission released a second interim report showing that the three largest pharmacy benefit managers — CVS Caremark, Express Scripts and OptumRX — marked up specialty generic drug ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...

If the fire has closed your doctor’s office, or if wait times will keep you from getting your medicine when you need it, you ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...